Non-insulin-dependent diabetes mellitus - A collision between thrifty genes and an affluent society

Annals of Medicine

Volumn 29, Issue 1, 1997, Pages 37-53

  Groop, Leif C ^a,b   Tuomi, Tiinamaija ^a  

^a LUND UNIVERSITY   (Sweden)

^b Malmo University Hospital   (Sweden)

Author keywords

Genetics; Insulin action; Insulin secretion; Non insulin dependent diabetes mellitus

Indexed keywords

INSULIN;

CALORIC INTAKE; DISEASE CLASSIFICATION; ENERGY CONSERVATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; LIFESTYLE; MOLECULAR BIOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; STARVATION;

EID: 0031026938     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899708998742     Document Type: Review

References (179)

1. Zimmet P. Diabetes care and prevention - around the world in 80 days. In: Rifkin HCJ, Taylor SI, eds. Diabetes. Elsevier, 1991: 721-9.
2. Serjeantson S, Owerbach D, Zimmet P, Nerup J, Thoma K. Genetics of diabetes in Nauru: Effects of foreign admixture, HLA antigens, and the insulin-gene linked polymorphism. Diabetologia 1983; 25: 13-17.
3. Brosseau J, Eelkema R, Crawford A, Abe T. Diabetes among the three affiliated tribes: correlation with degree of Indian inheritance. Am J Public Health 1979; 69: 1277-8.
4. Newman B, Selby J, King M, Slemenda C, Fabsitz R, Friedman G. Concordance for type 2 diabetes in male twins. Diabetologia 1987; 30: 763-8.
5. Kaprio J, Tuomilehto J, Koskenvuo M, et al. Concordance for type 1 and type 2 diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 1992; 35: 1060-7.
6. Köbberling J, Tillil H. Empiricial risk figures for first-degree relatives of non-insulin-dependent diabetics. In: Köbberling J, Tattersall R, eds. The Genetics of Diabetes Mellitus. London: Academic Press, 1982: 201-9.
7. Leslie R, Volkmann H, Poncher M, Hanning I, Orskov H, Alberti K. Metabolic abnormalities in children of non-insulin dependent diabetics. BMJ 1986; 293: 840-2.
8. Cook J, Shields D, Page R, et al. Segregation analysis of NIDDM in Caucasian families. Diabetologia 1994; 37: 1231-40.
9. Cook J, Hattersley A, Levy J, et al. Distribution of type II diabetes in nuclear families. Diabetes 1993; 42: 106-12.
10. Alcolado J, Alcolado R. Importance of maternal history of non-insulin-dependent diabetic patients. BMJ 1991; 302: 1178-80.
11. Groop L, Forsblom C, Lehtovirta M, et al. Metabolic consequences of a family history of NIDDM (The Botnia Study). Diabetes 1996; 45: 1585-93.
12. Thomas F, Balkau B, Vauzelle-Kervroedan F, Papoz L. Maternal effect and familial aggregation in NIDDM. The CODIAB Study. Diabetes 1994; 43: 63-7.
13. Mitchell B, Kammerer C, Reinhart L, Stern M, Mac Cluer J. Is there an excess in maternal transmission of NIDDM? Diabetologia 1995; 38: 314-7.
14. Gerbitz K-D, Gempel K, Brdiczka. Mitochondria and diabetes. Genetic, biochemical, and clinical implications of the cellular energy circuit. Diabetes 1996; 45: 113-26.
15. Maassen J, Kadowaki T. Maternally inherited diabetes and deafness: a new diabetes subtype. Diabetologia 1996; 39: 375-82.
16. Hales C, Barker D. Type 2 diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992; 35: 595-601.
17. Mc Cance D, Pettit D, Hanson R, Jakobsson L, Knowler W, Bennett P. Low birth weight and type 2 diabetes in Pima Indians. Diabetologia 1993; 36 (Suppl 1): A5.
18. Giddings S, King C, Harman K, Flood J, Carnaghi L. Allele specific inactivation of insulin 1 and 2, in the mouse yolk sac, indicates imprinting. Nat Genet 1994; 6: 310-3.
19. Ptacek L, Johnson K, Griggs R. Genetics and physiology of myotonic muscle disorders. N Engl J Med 1993; 328: 482-9.
20. Taylor S, Kadowaki T, Kadowaki H, Accili D, Cama A, McKeon C. Mutations in the insulin receptor gene in insulin-resistant patients. Diabetes Care 1991; 13: 257-9.
21. Marin P, Rebuffe-Scrive M, Smith U, Björntorp P. Glucose uptake in human adipose tissue. Metabolism 1987; 36: 1154-60.
22. Yki-Järvinen H. Acute and chronic effects of hyperglycemia on glucose metabolism. Diabetologia 1990; 33: 579-85.
23. Eriksson J, Franssila-Kallunki A, Ekstrand A, et al. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 1989; 321: 337-43.
24. Vaag A, Henriksen J, Beck-Nielsen H. Decreased activation of glycogen synthase in skeletal muscle of young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1992; 89: 782-8.
25. Gulli G, Ferrannini E, Stern M, Haffner S, DeFronzo R. The metabolic profile of NIDDM is fully established in glucosetolerant offspring of two Mexican-American parents. Diabetes 1992; 41: 1575-86.
26. Lillioja S, Mott D, Howard B, et al. Impaired glucose tolerance as disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 1987; 20: 87-93.
27. Lillioja S, Mott D, Spraul M, et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes meilitus. N Engt J Med 1993; 329: 1988-92.
28. Mitrakou A, Kelley D, Mokan M, et al. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 1992; 326: 22-9.
29. Pimenta W, Korytkowski M, Mitrakou A, et al. Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. JAMA 1995; 273: 1855-61.
30. Beck-Nielsen H, Groop L. Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes meilitus. J Clin Invest 1994; 94: 1714-21.
31. Schalin-Jäntti C, Härkönen M, Groop L. Impaired activation of glycogen synthase in people at increased risk for developing NIDDM. Diabetes 1992; 41: 598-604.
32. Kahn R. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 1994; 43: 1066-84.
33. Laakso M, Edelman S, Brechtel G, Baron A. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes 1992; 41: 1076-83.
34. Lillioja S, Young A, Culter C, et al. Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 1987; 80: 415-24.
35. Wells A, Sutcliffe I, Johnson A, Taylor R. Abnormal activation of glycogen synthase in fibroblasts from NIDDM patients. Evidence for an abnormality specific to glucose metabolism. Diabetes 1993; 42: 583-9.
36. Eriksson K-F, Saltin B, Lindgärde F. Increased skeletal muscle capillary density precedes diabetes development in men with impaired glucose tolerance. A 15-year follow-up study. Diabetes 1994; 43: 805-8.
37. Groop L, Bonadonna R, DelPrato S, et al. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes meilitus: evidence for multiple sites of insulin resistance. J Clin Invest 1989; 84: 205-13.
38. Hother-Nielsen O, Beck-Nielsen H. Insulin resistance, but normal rates of glucose production in patients with newly diagnosed mild diabetes meilitus. Acta Endocrinol 1991; 124: 637-45.
39. Consoli A, Nurjhan N, Reilly J Jr, Bier D, Gerich J. Mechanisms of increased gluconeogenesis in noninsulin-dependent diabetes meilitus. Role of alterations in systemic, hepatic and muscle lactate and alanine metabolism. J Clin Invest 1990; 86: 2038-45.
40. Puhakainen I, Koivisto V, Yki-Järvinen H. No reduction in total hepatic glucose output by inhibition of gluconeogenesis with ethanol in NIDDM patients. Diabetes 1991; 40: 1319-27.
41. Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in esstential hypertension. N Engl J Med 1987; 317: 350-7.
42. Widén E, Ekstrand A, Saloranta C, et al. Insulin resistance in type 2 diabetic patients with hypertriglyceridemia. Diabetologia 1992; 35: 1140-5.
43. Banerji M, Chaiken R, Gordon D, Kral J, Lebovitz H. Does intraabdominal adipose tissue in black men determine whether NIDDM is insulin-resistant or insulin-sensitive? Diabetes 1995; 44: 141-6.
44. Forsblom C, Eriksson J, Ekstrand A, Teppo A-M, Taskinen M-R, Groop L. Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM. Diabetolgia 1995; 38: 363-9.
45. Groop L, Ekstrand A, Forsblom C, et al. Insulin resistance, hypertension and microalbuminuria in patients with type 2 diabetes mellitus. Diabetologia 1993; 36: 642-7.
46. Vuorinen-Markkola H, Yki-Järvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 1994; 78: 25-8.
47. Reaven G. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
48. Ravussin E, Lillioja S, Knowler W, et al. Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med 1988; 318: 467-72.
49. Zurlo F, Lillioja S, Esposito-Del Puente A, et al. Low ratio of fat to carbohydrate oxidation as predictors of weight gain: study of 24 h RQ. Am J Physiol 1990; 259: E650-7.
50. Neel V. Diabetes mellitus: a 'thrifty' genotype rendered detrimental by progress? Am J Hum Genet 1962; 14: 352-62.
51. Coleman D. Obesity genes: beneficial effects in heterozygous mice. Science 1979; 203: 663-5.
52. Lönnqvist F, Thörne A, Nilsell K, Hoffstedt J, Arner P. A pathogenetic role of visceral fat beta-3-adrenoreceptors in obesity. J Clin Invest 1995; 95: 1109-16.
53. Krief S, Lönnqvist F, Raimbault S, et al. Tissue distribution of beta-3-adrenergic receptor mRNA in man. J Clin Invest 1993; 91: 344-9.
54. Reynisdotter S, Wahrenberg H, Carlström K, Rössner S, Arner P. Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta-2-adrenoceptors. Diabetologia 1994; 37: 428-35.
55. Zhang Y, Proenca R, Maffei M, Baron M, Leopold L, Friedman J. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-32.
56. Falholt K, Lindkaer IJ, Jensen S, et al. Carbohydrate and lipid metabolism of skeletal muscle in type 2 diabetic patients. Diabet Med 1987; 5: 27-31.
57. Borkman M, Storlien L, Pan D, Jenkins A, Chisholm D, Campbell L. The relation between insulin sensitivity and the fatty acid composition of skeletal muscle phospholipids. N Engl J Med 1993; 328: 238-44.
58. Storlien L, Jenkins A, Chisholm D, Pasqoe W, Kohouri S, Kraegen E. Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 1991; 40: 280-9.
59. Vessby B, Tengblad S, Lithell H. Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men. Diabetologia 1994; 37: 1044-50.
60. Groop L, Ferrannini E. Insulin action and substrate competition. Baillieres Clin Endocrinol Metab 1993; 7: 1007-32.
61. Cerasi E, Luft R. The plasma insulin response to glucose infusion in healthy subjects and in subjects with diabetes mellitus. Acta Endocrinol 1967; 55: 278-304.
62. Groop L, Widén E, Ferrannini E. Insulin resistance and insulin deficiency in the pathogenesis of type 2 diabetes mellitus: inborn errors of metabolism or of methods? Diabetologia 1993; 36: 1326-31.
63. O'Rahilly S, Turner R, Matthews D. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1988; 318: 1225-30.
64. Forsén T, Eriksson J, Suhonen L, Teramo K, Groop L. Gestational diabetes-type 2 diabetes with relative insulin deficiency. Duodecim 1994; 110: 808-14 (in Finnish).
65. Ekstrand A, Eriksson J, Grönhagen-Riska C, Ahonen P, Groop L. Insulin resistance and insulin deficiency in the pathogenesis of postransplantation diabetes in man. Transplantation 1992; 53: 563-9.
66. Groop L, Bottazzo G, Doniach D. Islet cell antibodies identify latent type 1 diabetes in patients aged 35-75 years at diagnosis. Diabetes 1986; 35: 237-41.
67. Hagopian W, Karlsen A, Gottsäter A, et al. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 65K autoantibody positivity at onset predicts diabetes type. J Clin Invest 1993; 91: 368-74.
68. Tuomi T, Groop L, Zimmet P, Rowley M, Knowles W, Mackay I. Antibodies to glutamic acid decarboxylase (GAD) identify latent IDDM in patients with onset of diabetes after the age of 35 years. Diabetes 1993; 42: 359-62.
69. Warram J, Martin B, Krolewski A, Soeldner J, Kahn R. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in offspring of diabetic parents. Ann Intern Med 1990; 113: 909-15.
70. Martin B, Warram J, Krolewski A, Bergman R, Soeldner J, Kahn C. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 1992; 340: 925-9.
71. Skarfors E, Selenus K, Lithell H. Risk factors for developing non-insulin-dependent diabetes mellitus: a 10-year follow-up of men in Uppsala. BMJ 1991; 303.
72. Ohlson L, Larsson B, Svärdsudd K, et al. The influence of body fat distribution on the incidence of diabetes mellitus: 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 1985; 34: 1055-8.
73. Laakso M, Barrett-Connor E. Asymtomatic hyperglycemia is associated with lipid and lipoprotein changes favouring atherosclerosis. Arteriosclerosis 1989; 9: 665-72.
74. Froguel P, Zouali H, Velho G, et al. Familial hyperglycemia dua to mutations in the glucokinase gene. N Engl J Med 1993; 328: 697-702.
75. Froguel P, Vaxillaire M, Sun F, et al. Close linkage of glucokinase locus on chromosome 7p to early onset non-insulin-dependent diabetes mellitus. Nature 1992; 356: 162-7.
76. Vaxillaire M, Boccio V, Philippi A, et al. A gene for early onset non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young) maps to chromosome 12 q. Natl Genet 1995; 9: 418-23.
77. Collins F. Positional cloning moves from perditional to traditional. Nat Genet 1995; 9: 347-50.
78. Hästbacka J, de la Chapelle A, Mahtani M, et al. The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping. Cell 1994; 78: 1073-87.
79. Galli J, Li L-S, Glaser A, et al. Genetic analysis of non-insulin dependent diabetes mellitus in the GK rat. Nat Genet 1996; 12: 31-7.
80. Gauguier D, Froguel P, Parent V, et al. Chromosomal mapping of genetic loci associated with non-insulin dependent diabetes in the GK rat. Nat Genet 1996; 12: 38-43.
81. Liang P, Pardee A. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992; 257: 967-71.
82. Reynet C, Kahn R. Rad: a member of the ras family overexpressed in muscle of type II diabetic humans. Science 1993; 262: 1441-3.
83. Aoki M, Koranyi L, Riggs A, et al. Identification of trinucleotide repeat-containing genes in human pancreatic islets. Diabetes 1996; 45: 157-64.
84. Kahn CR. Insulin action, diabetogenesis, and the cause of type II diabetes. Diabetes 1994; 73: 1066-84.
85. Freidenberg G, Reichart D, Olefsky J, Henry R. Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus: effect of weight loss. J Clin Invest 1991; 88: 1323-30.
86. Sun X, Rothenberg P, Kahn R, et al. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 1991; 352: 73-7.
87. Almind K, Bjoerbaek C, Vestergaard H, Hansen T, Echwald S, Pedersen O. Aminoacid polymorphism of the insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 1993; 342: 828-32.
88. Clausen J, Hansen T, Bjoerbaek C, et al. Insulin resistance: interactions between obesity and a common variant of the insulin receptor substrate-1. Lancet 1995; 346: 397-402.
89. Arakl E, Lypes M, Patti M, et al. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 1994; 372: 186-90.
90. Sun X, Wang L-M, Zhang Y, et al. Role of IRS-2 in insulin and cytokine signalling. Nature 1995; 377: 173-7.
91. Sasaoka T, Draznin B, Leitner J, Langlois W, Olefsky J. She is the predominant signaling molecule coupling insulin receptors to activation of guanine nucleotide releasing factor and p21 ras-GTP formation. J Biol Chem 1994; 269: 10734-8.
92. Le Marchand-Brustel Y, Gautier N, Cormont M, van Oberghen E. Wortmannin inhibits the action of insulin but not that of okadaic acid in skeletal muscle: Comparison with fat cells. Endocrinology 1995; 136: 3564-70.
93. Savitsky K, Bar-Shira A, Gilad S, et al. A single ataxia teleangiectasia gene with product similar to PI-3-kinase. Science 1995; 268: 1749-53.
94. Doria A, Caldwell J, Ji L, et al. Trinucleotide repeats at the rad locus. Allele distributions in NIDDM and mapping to a 3 cM region on chormosome 16q. Diabetes 1995; 44: 243-7.
95. Orho M, Carlsson M, Kanninen T, Groop L. Polymorphism at the rad gene is not associated with NIDDM in Finns. Diabetes 1996; 45: 429-33.
96. Cross D, Alessi D, Cohen P, Andjelkovich M, Hemmings B. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995; 378: 785-9.
97. Yki-Järvinen H, Mott D, Young A, Stone K, Bogardus C. Regulation of glycogen synthase and phosphorylase activities by glucose and insulin in human skeletal muscle. J Clin Invest 1987; 80: 95-100.
98. Miles P, Levisetti M, Reichart D, Khoursheed M, Moosa A, Olefsky J. Kinetics of insulin action in vivo. Identification of rate-limiting steps. Diabetes 1995; 44: 947-53.
99. Richter E, Asp Hansen S, Falck Hansen B. Mechanism limiting glycogen storage in muscle during prolonged insulin infusion. Am J Physiol 1988; 255: E621-8.
100. Kahn B. Facilatative glucose transporters: regulatory mechanisms and dysregulation in diabetes. J Clin Invest 1992; 89: 1367-74.
101. Schalin-Jäntti C, Yki-Järvinen H, Koranyi L, et al. Effect of insulin on GLUT-4 mRNA and protein concentrations in skeletal muscle of patients with NIDDM and their first-degree relatives. Diabetologia 1994; 37: 401-7.
102. Katz E, Stenbit A, Hatton K, DePinho R, Charron M. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature 1995; 377: 151-4.
103. Gibbs E, Stock J, McCoid S, et al. Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). J Clin Invest 1995; 95: 1512-8.
104. Bonadonna R, DelPrato S, Saccomanni M, et al. Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. J Clin Invest 1993; 92: 486-94.
105. Rothman D, Shulman R, Shulman G. P-nuclear magnetic resonance measurements of glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity. J Clin Invest 1992; 89: 1069-75.
106. Rothman D, Magnusson I, Cline G, et al. Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1995; 92: 983-7.
107. Lehto M, Huang X, Davis E, et al. Human hexokinase II gene: exon-intron organization, mutation screening in NIDDM, and its relationship to muscle hexokinase activity. Diabetologia 1995; 38: 1466-74.
108. Printz R, Ardehali H, Koch S, Granner D. Human hexokinase II mRNA and gene structure. Diabetes 1995; 44: 290-4.
109. Lehto M, Stoffel M, Groop L, Esplnosa R III, LeBeau M, Bell G. Assignment of the gene encoding gycogen synthase to human chromosome 19, band q13.3. Genomics 1993; 15: 460-1.
110. Orho M, Nikula-Ijäs P, Schalin-Jäntti C, Permutt M, Groop L. Isolation and characterization of the human muscle glycogen synthase gene. Diabetes 1995; 44: 1099-105.
111. Groop L, Kankuri M, Schalin-Jäntti C, et al. Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med 1993; 328: 10-4.
112. Zouali H, Velho G, Froguel P. Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med 1993; 328: 1568.
113. Majer M, Molt D, Mochizuki H, et al. Association of the glycogen synthase locus 19q13 with NIDDM in Pima Indians. Diabetologia 1996; 39: 314-21.
114. Kuroyama H, Sanke T, Ohangi S, Furuta M, Nanjo K. Simple tandem repeat DNA polymorphism in the human glycogen synthase gene is associated with NIDDM in Japanese subjects. Diabetologia 1994; 37: 536-9.
115. Shimokawa K, Kadowaki H, Sakura H, et al. Molecular scanning of the glycogen synthase and insulin receptor substrate-1 genes in Japanese subjects with non-insulin-dependent diabetes mellitus. Biochem Biophys Res Commun 1994; 202: 463-9.
116. Elbein S, Hoffman M, Ridinger D, Otterud B, Leppert M. Description of a second microsatellite marker and linkage analysis of the muscle glycogen synthase gene locus in familial NIDDM. Diabetes 1994; 43: 1061-5.
117. Elbein S, Chiu K, Hoffman M, Mayorga R, Bragg K, Leppert M. Linkage analysis of 19 candidate regions for insulin resistance in familial NIDDM. Diabetes 1995; 44: 1259-65.
118. Seldin M, Mott D, Bhat D, et al. Glycogen synthase: a putative locus for diet-induced hyperglycemia. J Clin Invest 1994; 94: 1-8.
119. Bjoerbaek C, Vik T, Echwald S, et al. Cloning of a human insulin-stimulated protein kinase (ISPK-1) gene and analysis of coding regions and mRNA levels of the ISPK-1 and the protein phosphatase-1 genes in muscle from NIDDM patients. Diabetes 1995; 44: 90-7.
120. Hansen L, Hansen T, Vestergaard H, et al. A widespread amino acid polymorphism at codon 905 of the glycogen-associated regulatory subunit of protein phoshatase-1 is associated with insulin resistance and hypersecretion of insulin. Hum Mol Genet 1995; 4: 1313-20.
121. Coleman D. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 1973; 9: 294-8.
122. Pelleymounter M, Cullen M, Baker M, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-2.
123. Consindine R, Consindine E, William C, et al. Evidence against either a premature stop codon or the abscence of obese gene mRNA in human obesity. J Clin Invest 1995; 95: 2986-8.
124. Consindine R, Sinha M, Heiman M, et al. Serum immunoreactive leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-5.
125. Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995; 1: 1155-61.
126. Ogawa Y, Masuzaki H, Isse N, et al. Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa/fa) rats. J Clin Invest 1995; 96: 1647-52.
127. Tartaglia L, Dembski M, Weng X, et al. Identification and expression cloning of a leptin receptor, ob-R. Cell 1996; 83: 1263-71.
128. Lee G-H, Proenca R, Montez J, et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996; 379: 632-5.
129. Stephens T, Basinski M, Bristow P, et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995; 377: 530-2.
130. Naggert J, Fricker L, Varlamov O, et al. Hyperproinsulinemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat Genef 1995; 10 :135-42.
131. Emorine L, Marullo S, Briend-Sutren M, et al. Molecular characterization of the human beta-3-adrenergic receptor. Science 1989; 245: 1118-21.
132. Lowell B, Susulic V, Hamman A, et al. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 1993; 366: 740-2.
133. Walston J, Silver K, Bogardus C, et al. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta3-adrenergic-receptor gene. N Engl J Med 1995; 333: 343-7.
134. Clément K, Vaisse C, Manning B, et al. Genetic variation in the beta3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. New Engl J Med 1995; 333: 352-4.
135. Widèn E, Lehto M, Kanninen T, Walston J, Shuldiner A, Groop L. Association of a polymorphism in the beta-3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995; 333: 348-51.
136. Fujisawa T, Ikegami H, Yamato E, et al. Association of Trp64Arg mutation of the beta3-adrenergic receptor with NIDDM and body weight gain. Diabetologia 1996; 39: 349-52.
137. Hotamisigil G, Arner P, Caro J, Atkinson R, Spiegelman B. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-15.
138. Hotamisligil G, Shargill N, Spiegelman B. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
139. Kellerer M, Rett K, Kroder G, Groop L, Häring H. Circulating TNF-alpha levels and insulin sensitivity in man. Horm Metab Res (in press).
140. Saghizadeh M, Ong J, Garvey W, Henry R, Kern P. The expression of TNF-alpha by human muscle. Relationship to insulin resistance. J Clin Invest 1996; 97: 1111-6.
141. Norman R, Bogardus C, Ravussin E. Linkage between obesity and a marker near the tumor necrosis factor alpha locus in Pima Indians. J Clin Invest 1995; 96: 158-62.
142. Himms-Hagen J. Brown adipose tissue thermogenesis, energy balance and obesity. Can J Biochem Cell Biol 1984; 62: 610-7.
143. Kopecky J, Clarke G, Enerbäck S, Spiegelman B, Kozak L. Expression of the imtochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity. J Clin Invest 1995; 96: 2914-23.
144. Turton M, O'Shea D, Gunn I, et al. A role for glucagon-like-peptide-1 in the central regulation of feeding. Nature 1996; 379: 69-72.
145. Tuomilehto-Wolf E, Tuomilehto J, Hitman G, et al. Genetic susceptibility to non-insulin-dependent diabetes mellitus and glucose intolerance are located in HLA region. BMJ 1993; 307: 155-9.
146. Groop L, Groop P, Koskimies S. Relationship between beta-cell function and HLA-antigens in patients with type 2 diabetes. Diabetologia 1986; 29: 757-60.
147. Rich S, French L, Sprafka J, Clements J, Goetz F. HLA-associated susceptibility to type 2 diabetes mellitus: the Wadena city health study. Diabetologia 1993; 36: 234-8.
148. Groop L, Bottazzo G. Genetic susceptibility to non-insulin-dependent diabetes mellitus. BMJ 1994; 308: 504.
149. Li H, Tuomi T, Orho M, Groop L. Sharing an HLA-haplotype with an IDDM-relative influences insulin secretion in NIDDM and IGT. Diabetes 1996; 45: 296A.
150. Davies J, Kawaguchi Y, Bennett S, et al. A genome-wide search for human type 1 diabetes-susceptibility genes. Nature 1994; 371: 130-6.
151. Hashimoto L, Habita C, Beressi J, et al. Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature 1994; 371: 161-4.
152. Rotwein P, Chirgwin J, Province M, et al. Polymorphism in the 5′-flanking region of the human insulin gene: a genetic marker for non-insulin-dependent diabetes mellitus. N Engl J Med 1983; 308: 65-71.
153. Bennett S, Lucassen A, Gough S, et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet 1995; 9: 284-92.
154. Kennedy G, German M, Rutter W. The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription. Nat Genet 1995; 9: 293-8.
155. Kadowaki T, Kadowaki H, Mori Y, et al. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 1994; 330: 962-8.
156. van den Ouwenland J, Lemkes H, Ruitenbeek W, et al. Mutation in mitochondrial tRNA (Leu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1992; 1: 368-71.
157. Bell G, Xiang K-S, Newman M, et al. Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. Proc Natl Acad Sci USA 1991; 88: 1484-8.
158. Byrne M, Sturis J, Fajans S, et al. Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes 1995; 44: 699-704.
159. Gidh-Jain M, Takeda J, Wu L, et al. Glucokinase mutations associated with non-insulin-dependent diabetes mellitus (type II) have decreased enzymatic activity: implications for structure/functions relationships. Proc Natl Acad Sci USA 1993; 90: 1932-6.
160. Velho G, Froguel P, Clement K, et al. Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young. Lancet 1992; 340: 444-8.
161. Aguilar-Bryan L, Nichols C, Wechsler S, et al. Cloning of the beta-cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science 1995; 268: 423-5.
162. Inagaki N, Gonol T, Clement JI, et al. Reconstitution of I KATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 1995; 268: 423-6.
163. Iwasaki N, Kawamura M, Yamagata K, et al. Identification of microsatellite markers near the human genes encoding the beta-cell ATP-sensitivie K channel and linkage studies with NIDDM in Japanese. Diabetes 1996; 45: 267-9.
164. Stirling B, Cox N, Bell G, Hanis C, Spielman R, Concannon P. Linkage studies in NIDDM with markers near the sulphonylurea receptor gene. Diabetologia 1995; 38: 1479-81.
165. Zhang Y, Warren-Perry M, Sakura H, et al. No evidence for mutations in a putative beta-cell ATP-sensitive K-channel subunit in MODY, NIDDM or GDM. Diabetes 1995; 44: 597-600.
166. émmälä C, Moorehouse A, Gribble F, et al. Promiscuous coupling between the sulphonylurea receptor and inwardly rectifying potassium channels. Nature 1996; 379: 545-8.
167. Hager J, Hansen L, Vaisse C, et al. A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus. Nat Genet 1995; 9: 299-304.
168. Huang X, Orho M, Lehto M, Groop L. Lack of association between the Gly40Ser polymorphism in the glucagon receptor gene and NIDDM in Finland. Diabetologia 1995; 38: 1246-8.
169. Fujisawa T, Ikegami H, Yamato E, et al. A mutation in the glucagon receptor gene (Gly40Ser): heterogeneity in the association with diabetes mellitus. Diabetologia 1995; 38: 983-5.
170. Ghosh S, Schork N. Genetic analysis of NIDDM. The study of quantitative traits. Diabetes 1996; 45: 1-14.
171. Baier L, Sacchettini J, Knowler W, et al. An amino acid Substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation and insulin resistance. J Clin Invest 1995; 95: 1281-7.
172. Mitchell B, Kammerer C, O'Connell P, et al. Evidence for linkage of postchallenge insulin levels with intestinal fatty-acid-binding protein (FAB2) in Mexican Americans. Diabetes 1995; 44: 1046-53.
173. Humphreys P, McCarthy M, Tuomilehto J, et al. Chromosome 4q locus associated with insulin resistance in Pima Indians. Studies in three European populations. Diabetes 1994; 43: 800-4.
174. Thompson D, Janssen R, Ossowski V, Prochazka M, Knowler W, Bogardus C. Evidence for linkage between a region on chromosome 1p and the acute insulin response in Pima Indians. Diabetes 1995; 44: 478-81.
175. Elbein S, Bragg K, Hoffman M, Mayorga A, Leppert M. Linkage studies of NIDDM with 23 chromosome 11 markers in a sample of whites of Northern European descent. Diabetes 1996; 45: 370-5.
176. Hanis C, Boerwinkle E, Chakraborty R, et al. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 1996; 13: 161-6.
177. Mahtani M, Widen E, Lehto M, et al. Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat Genet 1996: 90-4.
178. Lander E, Kruglyak L. Genetic dissection of complex traits', guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11: 241-7.
179. Lander E, Schork N. Genetic dissection of complex traits. Science 1994; 265: 2037-48.